Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.
Steward WP, Verweij J, Somers R, Blackledge G, Clavel M, Van Oosterom AT, Greifenberg B, Soedirman J, Thomas D, Van Glabbeke M, et al. Steward WP, et al. Among authors: clavel m. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S193-7. doi: 10.1007/BF01613226. J Cancer Res Clin Oncol. 1991. PMID: 1795008 Clinical Trial.
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Steward WP, Verweij J, Somers R, Spooner D, Kerbrat P, Clavel M, Crowther D, Rouesse J, Tursz T, Tueni E, et al. Steward WP, et al. Among authors: clavel m. J Clin Oncol. 1993 Jan;11(1):15-21. doi: 10.1200/JCO.1993.11.1.15. J Clin Oncol. 1993. PMID: 8418226
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma Group.
Steward WP, Verweij J, Somers R, Spooner D, Kerbrat P, Clavel M, Crowther D, Rouesse J, Tursz T, Tueni E, et al. Steward WP, et al. Among authors: clavel m. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S241-4. Cancer Chemother Pharmacol. 1993. PMID: 8453707
A phase II study of carboplatin in advanced or metastatic stomach cancer.
Beer M, Cavalli F, Kaye SB, Lev LM, Clavel M, Smyth J, van Glabbeke M, Renard J, Pinedo HM. Beer M, et al. Among authors: clavel m. Eur J Cancer Clin Oncol. 1987 Oct;23(10):1565-7. doi: 10.1016/0277-5379(87)90101-5. Eur J Cancer Clin Oncol. 1987. PMID: 3315695 No abstract available.
533 results